WOODCLIFF LAKE, N.J., Feb. 10, 2020 /PRNewswire/ -- Eisai announced today the presentation of three abstracts at the 2020 Genitourinary Cancers Symposium (#GU20) in San Francisco from February 13-15. New data to be presented on lenvatinib (marketed as LENVIMA®) include results from a...
from PR Newswire: https://ift.tt/31GEOoa
No comments:
Post a Comment